Arkolith/Insider Trading/PNT/Form 4

Malik Rajesh

DirectorPOINT Biopharma Global Inc. (PNT) · full profile →Form 4 · filed Nov 28, 2022
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 28, 2022Buy(P)4K$6.66$25K4K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-122390) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML